Clinical Trial

Placebo Effect on Cycling Performance: Laboratory Crossover Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to determine the impact of the placebo (PLA) effect on physical and cognitive performance in a controlled laboratory setting. The study investigates how expectations and beliefs about substance intake (caffeine vs. placebo) interact with actual consumption to influence performance and physiological stress markers. Healthy adults (n = 80) will participate in four testing sessions using a randomized, double-blind, placebo-controlled crossover design. Physiological stress markers (cortisol and alpha-amylase), heart rate, and performance metrics will be monitored during a standardized cycling exercise protocol. This phase provides the dense mechanistic data required to refine a mathematical model of the placebo effect, offering insights into how individual personality traits and cognitive anchoring influence psychophysiological potential.
Trial Details
NCT Number NCT07748429
Lead Sponsor Poznan University of Physical Education
Conditions Physical Performance, Placebo Effect, Cognitive Performance
Enrollment 80 participants
Start Date 2026-10-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-05